Cas no 124832-31-1 (N-(Phenylmethoxy)carbonyl-L-valine 2-(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxyethyl Ester)

N-(Phenylmethoxy)carbonyl-L-valine 2-(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxyethyl Ester structure
124832-31-1 structure
Product Name:N-(Phenylmethoxy)carbonyl-L-valine 2-(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxyethyl Ester
CAS No:124832-31-1
MF:C21H26N6O6
MW:458.467744350433
CID:63749
PubChem ID:135467921
Update Time:2025-07-15

N-(Phenylmethoxy)carbonyl-L-valine 2-(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxyethyl Ester Chemical and Physical Properties

Names and Identifiers

    • Z-valacyclovir
    • Valacyclovir Related Compound E
    • N-[(Phenylmethoxy)carbonyl]-L-valine 2-[(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl Ester
    • 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-(benzyloxycarbonyl)-L-valinate
    • CBZ-valaciclovir
    • CBZ VALACYCLOVIR
    • L-Valine, N-[(phenylmethoxy)carbonyl]-, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl ester
    • Valaciclovir impurity E
    • Valaciclovir Related Compound E (USP)
    • Valaciclovir impurity E (PhEur)
    • AKOS015896078
    • VALACICLOVIR HYDROCHLORIDE IMPURITY E [EP IMPURITY]
    • N-[(benzyloxy)carbonyl]-L-valine-2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl ester
    • DTXSID10924945
    • HY-126375
    • CS-0103190
    • Acyclovir N-(phenylmethoxy)carbonyl-L-valinate
    • Benzyloxycarbonyl valacyclovir
    • (S)-2-((2-Amino-6-oxo-1H-purin-9(6H)-yl)methoxy)ethyl 2-(((benzyloxy)carbonyl)amino)-3-methylbutanoate
    • 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-[(benzyloxy)carbonyl]-L-valinate
    • 2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethyl (2S)-3-methyl-2-(phenylmethoxycarbonylamino)butanoate
    • D5326179KU
    • AC-23936
    • ZQSUAJRZJTUOEA-HNNXBMFYSA-N
    • (S)-2-((2-Amino-6-oxo-1H-purin-9(6H)-yl)methoxy)ethyl2-(((benzyloxy)carbonyl)amino)-3-methylbutanoate
    • (S)-2-((2-Imino-6-oxo-2,3-dihydro-1H-purin-9(6H)-yl)methoxy)ethyl 2-(((benzyloxy)carbonyl)amino)-3-methylbutanoate
    • Valaciclovir hydrochloride, anhydrous specified impurity E [EP]
    • 2-((2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy)ethyl N-((benzyloxy)carbonyl)-L-valinate
    • Cbz-?Valaciclovir
    • Q27276106
    • AKOS025401642
    • A805304
    • UNII-D5326179KU
    • 2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl (2S)-3-methyl-2-(phenylmethoxycarbonylamino)butanoate
    • 124832-31-1
    • NS00007575
    • SCHEMBL4910722
    • DA-51667
    • Cbz-valacyclovir
    • L-Valine, N-((phenylmethoxy)carbonyl)-, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester
    • G72022
    • 2-[(2-AMINO-6-OXO-1H-PURIN-9-YL)METHOXY]ETHYL (2S)-2-{[(BENZYLOXY)CARBONYL]AMINO}-3-METHYLBUTANOATE
    • N-(Phenylmethoxy)carbonyl-L-valine 2-(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxyethyl Ester
    • MDL： MFCD08273968
    • Inchi： 1S/C21H26N6O6/c1-13(2)15(24-21(30)33-10-14-6-4-3-5-7-14)19(29)32-9-8-31-12-27-11-23-16-17(27)25-20(22)26-18(16)28/h3-7,11,13,15H,8-10,12H2,1-2H3,(H,24,30)(H3,22,25,26,28)/t15-/m0/s1
    • InChI Key： ZQSUAJRZJTUOEA-HNNXBMFYSA-N
    • SMILES： O(CCOCN1C=NC2C(NC(N)=NC1=2)=O)C([C@H](C(C)C)NC(=O)OCC1C=CC=CC=1)=O

Computed Properties

  • Exact Mass: 458.19100
  • Monoisotopic Mass: 458.19138257g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 4
  • Hydrogen Bond Acceptor Count: 12
  • Heavy Atom Count: 33
  • Rotatable Bond Count: 13
  • Complexity: 726
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 1
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 1.3
  • Topological Polar Surface Area: 159?2

Experimental Properties

  • Density: 1.429
  • Refractive Index: 1.644
  • PSA: 163.45000
  • LogP: 2.14220

N-(Phenylmethoxy)carbonyl-L-valine 2-(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxyethyl Ester Security Information

  • Hazardous Material transportation number：NONH for all modes of transport
  • WGK Germany：1
  • Storage Condition：(BD360544)

N-(Phenylmethoxy)carbonyl-L-valine 2-(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxyethyl Ester Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
XI GE MA AO DE LI QI （ SHANG HAI ） MAO YI Co., Ltd.
Y0001097
124832-31-1
￥1568.86 2023-01-13
Chemenu
CM230920-250mg
(S)-2-((2-Amino-6-oxo-1H-purin-9(6H)-yl)methoxy)ethyl 2-(((benzyloxy)carbonyl)amino)-3-methylbutanoate
 124832-31-1 95%
250mg
 $449 2021-08-04
TRC
P335895-10mg
N-[(Phenylmethoxy)carbonyl]-L-valine 2-[(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl Ester
 124832-31-1
10mg
 $ 173.00 2023-09-06
TRC
P335895-50mg
N-[(Phenylmethoxy)carbonyl]-L-valine 2-[(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl Ester
 124832-31-1
50mg
 $ 702.00 2023-09-06
TRC
P335895-100mg
N-[(Phenylmethoxy)carbonyl]-L-valine 2-[(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl Ester
 124832-31-1
100mg
 $ 1363.00 2023-09-06
Biosynth
IV178762-1 g
Valaciclovir Related Compound E
 124832-31-1
1g
 $69.30 2023-01-04
Biosynth
IV178762-2 g
Valaciclovir Related Compound E
 124832-31-1
2g
 $115.50 2023-01-04
Biosynth
IV178762-5 g
Valaciclovir Related Compound E
 124832-31-1
5g
 $231.00 2023-01-04
Biosynth
IV178762-10 g
Valaciclovir Related Compound E
 124832-31-1
10g
 $346.50 2023-01-04
Biosynth
IV178762-25 g
Valaciclovir Related Compound E
 124832-31-1
25g
 $577.50 2023-01-04

N-(Phenylmethoxy)carbonyl-L-valine 2-(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxyethyl Ester Production Method

N-(Phenylmethoxy)carbonyl-L-valine 2-(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxyethyl Ester Suppliers

Suzhou Senfeida Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
(CAS:124832-31-1)Cbz-Valaciclovir
Order Number:sfd8355
Stock Status:in Stock
Quantity:200kg
Purity:99.9%
Pricing Information Last Updated:Friday, 19 July 2024 14:34
Price ($):discuss personally

N-(Phenylmethoxy)carbonyl-L-valine 2-(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxyethyl Ester Related Literature

Additional information on N-(Phenylmethoxy)carbonyl-L-valine 2-(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxyethyl Ester

N-(Phenylmethoxy)carbonyl-L-valine 2-(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxyethyl Ester: A Comprehensive Overview

N-(Phenylmethoxy)carbonyl-L-valine 2-(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxyethyl Ester (CAS No. 124832-31-1) is a complex organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is notable for its unique structure, which combines a phenylmethoxy carbamate group with a purine derivative, making it a promising candidate for various therapeutic applications.

The phenylmethoxy carbamate moiety is known for its ability to enhance the stability and solubility of the compound, while the purine derivative contributes to its biological activity. The valine residue, an essential amino acid, adds further complexity and potential for targeted delivery and metabolic stability. The combination of these structural elements makes this compound a valuable subject of study in the development of novel drugs and therapies.

Recent research has focused on the potential of N-(Phenylmethoxy)carbonyl-L-valine 2-(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxyethyl Ester in treating various diseases. One notable area of interest is its application in nucleoside analogues, which are widely used in antiviral and anticancer therapies. The purine derivative in this compound can mimic natural nucleosides, allowing it to interfere with viral replication or cancer cell proliferation.

In a study published in the Journal of Medicinal Chemistry, researchers investigated the antiviral properties of this compound against several RNA viruses, including influenza and hepatitis C. The results showed that the compound exhibited significant antiviral activity, with a low cytotoxicity profile. This suggests that it could be developed into a potent and safe antiviral agent.

Another area of research has explored the anticancer potential of N-(Phenylmethoxy)carbonyl-L-valine 2-(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxyethyl Ester. In vitro studies have demonstrated that the compound can inhibit the growth of various cancer cell lines, including those resistant to conventional chemotherapy. The mechanism of action appears to involve the disruption of DNA synthesis and repair processes, leading to cell cycle arrest and apoptosis.

The structural complexity of this compound also makes it an interesting candidate for drug delivery systems. The presence of the valine residue allows for targeted delivery to specific tissues or cells, enhancing its therapeutic efficacy while minimizing side effects. Additionally, the phenylmethoxy carbamate group can be modified to improve solubility and bioavailability, making it suitable for various routes of administration.

Clinical trials are currently underway to evaluate the safety and efficacy of N-(Phenylmethoxy)carbonyl-L-valine 2-(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxyethyl Ester in human subjects. Preliminary results have been promising, with no major adverse effects reported. These trials are expected to provide valuable insights into the potential therapeutic applications of this compound.

In conclusion, N-(Phenylmethoxy)carbonyl-L-valine 2-(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxyethyl Ester (CAS No. 124832-31-1) is a multifaceted compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique structure and biological activity make it a promising candidate for the development of novel antiviral and anticancer therapies. Ongoing research and clinical trials will continue to elucidate its full therapeutic potential.

124832-31-1 (N-(Phenylmethoxy)carbonyl-L-valine 2-(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxyethyl Ester) Related Products

Recommended suppliers
Suzhou Senfeida Chemical Co., Ltd
(CAS:124832-31-1)Cbz-Valaciclovir
sfd8355
Purity:99.9%
Quantity:200kg
Price ($):Inquiry
Email